You are here

Applications of the ALBA Synchrotron for the Pharmaceutical Industry

Activity start date:  17.06.2022 - 09:30
Activity end date:  17.06.2022 - 15:00

Organized by: 

Sincrotrón ALBA and Biocat

Venue: 

ALBA Synchrotron - Carrer de la Llum, 2, 26, 08290 Cerdanyola del Vallès, Barcelona

The conference Applications of the ALBA Synchrotron for the Pharmaceutical Industry is organized by the ALBA Synchrotron in conjunction with Biocat, and aims to show pharmaceutical companies the applications of synchrotron light, which include critical stages for the sector such as the design of new drugs or the characterization of the active ingredients in the final formulation, among others.

During the meeting, practical examples of the most suitable techniques available at ALBA for this industrial sector will be shown; including success stories of client companies, a visit to the facilities and as a closing a networking lunch where you can consult the specialized staff of ALBA.

The language of the day will be Spanish, although some of the talks will be in English.

Program
09:00 Accreditations

SESSION I - Welcome and introduction

  • 09:30 - Welcome and introduction to the ALBA Synchrotron
    • Caterina Biscari, Director of the ALBA Synchrotro
    • Klaus Attenkofer, Scientific Director of the ALBA Synchrotron 
  • 09:40 - Welcome and introduction to Biocat
    • Núria Martí, Director of Innovation and Business Development at Biocat
  • 09:50 How it works and what the ALBA synchrotron is for
    • Miguel Ángel García Aranda, Professor at the University of Málaga, Scientific Director of ALBA 2013-2019

SESSION II - Industrial applications of synchrotron light for drug characterization

  • 10:10 a.m. Powder diffraction with synchrotron light for the pharmaceutical industry - Alexander Missyul MSPD Beamline Scientist
  • 10:25 a.m. Application of x-ray absorption spectroscopy to the study of pharmaceutical compounds - Vlad Martin-Diaconescu Scientist of the CLAESS beamline
  • 10:35 a.m. Release and characterization of pharmaceutical products by X-ray scattering - Cristian Huck Beamline Scientist NCD-SWEET
  • 10:45 a.m. Case study company user of the ALBA Synchrotron: Crysforma - Jordi Cerón, Unit Manager, CRYSFORMA-ICIQ
  • 11:00 a.m. Case study company user of the ALBA Synchrotron: Enantia - Joan Farran, Head of the Solid State Analysis Department, ENANTIA

11:15 Break

SESSION III - Industrial applications of synchrotron light for the design of drugs and their effects

  • 11:45 a.m. Crystallography: a key tool for the design of new drugs and biosimilars - Roeland Boer Responsible for the XALOC line
  • 12:00 pm Monitoring of the biological response to pharmaceutical treatments using FTIR - Tanja Ducic Scientist of the MIRAS beamline
  • 12:10 pm Applications in biomedicine of X-Ray Cryotomography - Ana Joaquina Pérez-Berná Scientist of the MISTRAL beamline
  • 12:20 pm Case study company user of the ALBA Synchrotron - Eli Lilly and Company, Jordi Benach Director de la línea LRL-CAT, Discovery-Chemistry Research and Technology, Eli Lilly and Company

SESSION IV - How the industry accesses the ALBA Synchrotron and discussion

  • 12:35 pm How to work with the ALBA Synchrotron - Alejandro Sánchez Director of the ALBA industrial office
  • 12:45 pm General discussion and conclusions of the day
  • 13:00 pm Visit to the ALBA synchrotron facilities

14:00 pm Food-Networking

15:00 pm End

More information:

AddToAny buttons: 
Mo Tu We Th Fr Sa Su
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31